Methotrexate-related drug reactions on kidneys and liver in rheumatoid arthritis: an analysis of spontaneous reports in EudraVigilance
14.3 MOUNJARO Use in Combination with Metformin, Sulfonylureas, and/or SGLT2 Inhibitors in Adult Patients with Type 2 Diabetes Mellitus Add-on to metformin SURPASS-2 (NCT03987919) was a 40-week open-label trial (double-blind with respect to MOUNJARO dose assignment) that randomized 1879 adult patients with type 2 diabetes mellitus with inadequate glycemic control on stable doses of metformin alone to the addition of subcutaneous MOUNJARO 5 mg, MOUNJARO 10 mg, or MOUNJARO 15 mg once weekly or subcutaneous semaglutide 1 mg once weekly
12 Fish and Seafood: Salmon, tuna, cod, shrimp, scallops
The 20% reduction in cardiovascular events seen in the SELECT trial may not be entirely explained by weight loss
Safety Information and Proper Use Aseptic Technique: The Critical Foundation for Multi-Dose Safety The safety of bacteriostatic water in multi-dose vials depends entirely on aseptic techniquethe use of sterile equipment and procedures to prevent contamination